Journal of Muscle Research and Cell Motility Biochemistry

Endocannabinoid system remodeling in human myopathies: a meta-analysis of skeletal muscle transcriptomes

Kural, Irem, Vanderbeke, Kaat, Koppo, Katrien, Gebruers, Nick, Lauriks, Wout, Dalle, Sebastiaan
Springer Nature · 2026-11-21 · DOI 10.1007/s10974-026-09743-0

Abstract

Preclinical studies indicate that the endocannabinoid system plays an important role in skeletal muscle inflammation, regeneration and metabolism, yet its involvement in human myopathies remains undefined. This study systematically investigated whether endocannabinoid system remodeling occurs in muscle of patients with myopathies. A retrospective meta-analysis was performed using publicly available bulk RNA-sequencing datasets from the Gene Expression Omnibus. In total, 328 muscle biopsies from patients with limb-girdle muscular dystrophy, myotonic dystrophy type 1, facioscapulohumeral muscular dystrophy, inflammatory myopathies, Duchenne/Becker muscular dystrophy, mitochondrial and collagen VI-related myopathy, and 173 control samples were included. Differential expression analyses were conducted per dataset using DESeq2, followed by random-effects meta-analyses for endocannabinoid targets and key endocannabinoid enzymes, with false discovery rate correction. Across disease subtypes, consistent remodeling of the endocannabinoid system was observed. Cannabinoid receptor 1 (CNR1) expression was overall upregulated (log2FC = 0.43, q < 0.001), while fatty acid amide hydrolase (FAAH), the primary enzyme responsible for anandamide and N-acylethanolamine degradation, was consistently downregulated (log2FC = -0.56, q < 0.001). CNR1 exhibited the lowest heterogeneity of all genes analyzed. Enzymes involved in 2-arachidonoylglycerol metabolism displayed disease-specific regulation. Results were robust to sex adjustment and alternative models. This meta-analysis provides the first comprehensive evidence that endocannabinoid signaling is consistently remodeled in human myopathies, across myopathies of different etiology. The downregulation of FAAH and upregulation of CNR1 suggest altered endocannabinoid tone as a shared feature of muscle degeneration. These findings support integrative studies combining longitudinal endocannabinoid and clinical data to understand how endocannabinoid remodeling drives muscle plasticity.

Read at publisher →